Clinical Trial Update: Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dapagliflozin and gemigliptin on ketone metabolism and cardiac remodeling in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus
• Ventricular Remodeling

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Gemigliptin (gemigliptin)

Snippet

Sponsor: Wonju Severance Christian Hospital | Conditions: Type2 Diabetes, Remodeling, Ventricular | Phase 4 | Status: UNKNOWN